Ingrid Vander Elst

1.5k total citations
22 papers, 1.1k citations indexed

About

Ingrid Vander Elst is a scholar working on Epidemiology, Hepatology and Physiology. According to data from OpenAlex, Ingrid Vander Elst has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 13 papers in Hepatology and 5 papers in Physiology. Recurrent topics in Ingrid Vander Elst's work include Liver Disease Diagnosis and Treatment (15 papers), Liver Disease and Transplantation (12 papers) and Drug Transport and Resistance Mechanisms (4 papers). Ingrid Vander Elst is often cited by papers focused on Liver Disease Diagnosis and Treatment (15 papers), Liver Disease and Transplantation (12 papers) and Drug Transport and Resistance Mechanisms (4 papers). Ingrid Vander Elst collaborates with scholars based in Belgium, Germany and Spain. Ingrid Vander Elst's co-authors include Frederik Nevens, Wim Laleman, Petra Windmolders, Tania Roskams, Jonel Trebicka, Len Verbeke, Ricard Farré, Marcel Zeegers, Johan Fevery and Sabine Klein and has published in prestigious journals such as PLoS ONE, Hepatology and Gut.

In The Last Decade

Ingrid Vander Elst

22 papers receiving 1.1k citations

Peers

Ingrid Vander Elst

EPIDE

HEPAT

SURGE

ONCOL

Jan Best Germany

Sun-Sang Wang Taiwan

Elisabeth Lasnier France

Sherry Boyett United States

Kuei‐Chuan Lee Taiwan

Pekka Pikkarainen Finland

Abeba Habtesion United Kingdom

J N Baxter United Kingdom

Stefan Strahl Germany

Vaishali Patel United States

Jan Best Germany

Ingrid Vander Elst

688 ×1.0

EPIDE

551 ×0.8

HEPAT

261 ×0.8

SURGE

214 ×0.8

ONCOL

264 ×1.4

Citations per year, relative to Ingrid Vander Elst Ingrid Vander Elst (= 1×) peers Jan Best

Countries citing papers authored by Ingrid Vander Elst

Since Specialization

Citations

This map shows the geographic impact of Ingrid Vander Elst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid Vander Elst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid Vander Elst more than expected).

Fields of papers citing papers by Ingrid Vander Elst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingrid Vander Elst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid Vander Elst. The network helps show where Ingrid Vander Elst may publish in the future.

Co-authorship network of co-authors of Ingrid Vander Elst

This figure shows the co-authorship network connecting the top 25 collaborators of Ingrid Vander Elst. A scholar is included among the top collaborators of Ingrid Vander Elst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingrid Vander Elst. Ingrid Vander Elst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bird, Matthew, Petra Windmolders, Ingrid Vander Elst, et al.. (2019). Oxygraphy Versus Enzymology for the Biochemical Diagnosis of Primary Mitochondrial Disease. Metabolites. 9(10). 220–220. 4 indexed citations

Chen, Feng, Louis Libbrecht, Ingrid Vander Elst, et al.. (2017). Everolimus halts hepatic cystogenesis in a rodent model of polycystic-liver-disease. World Journal of Gastroenterology. 23(30). 5499–5499. 10 indexed citations

Verbeek, Jef, Pascal Spincemaille, Ilse Vanhorebeek, et al.. (2017). Dietary intervention, but not losartan, completely reverses non-alcoholic steatohepatitis in obese and insulin resistant mice. Lipids in Health and Disease. 16(1). 46–46. 16 indexed citations

Verbeke, Len, Inge Mannaerts, Robert Schierwagen, et al.. (2016). FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis. Scientific Reports. 6(1). 33453–33453. 183 indexed citations

Plessis, Johannie du, Hannelie Korf, Jos van Pelt, et al.. (2016). Pro-Inflammatory Cytokines but Not Endotoxin-Related Parameters Associate with Disease Severity in Patients with NAFLD. PLoS ONE. 11(12). e0166048–e0166048. 64 indexed citations

Peeters, Geert, Charlotte Debbaut, Wim Laleman, et al.. (2016). A multilevel framework to reconstruct anatomical 3D models of the hepatic vasculature in rat livers. Journal of Anatomy. 230(3). 471–483. 21 indexed citations

Verbeke, Len, Inge Mannaerts, Robert Schierwagen, et al.. (2016). In Toxic Cirrhotic Rats, the FXR Agonist Obeticholic Acid Reduces Liver Fibrosis Indirectly via an Anti-Inflammatory Effect in Liver Sinusoidal Endothelial Cells and Kupffer Cells. Journal of Hepatology. 64(2). S141–S141. 1 indexed citations

Verbeke, Len, Ricard Farré, Bert Verbinnen, et al.. (2015). The FXR Agonist Obeticholic Acid Prevents Gut Barrier Dysfunction and Bacterial Translocation in Cholestatic Rats. American Journal Of Pathology. 185(2). 409–419. 170 indexed citations

Verbeke, Len, Inge Mannaerts, Robert Schierwagen, et al.. (2015). P0445 : Obeticholic acid, an FXR agonist, reduces hepatic fibrosis in a rat model of toxic cirrhosis. Journal of Hepatology. 62. S479–S479. 1 indexed citations

10.

Verbeek, Jef, Matthias Lannoo, Eija Pirinen, et al.. (2014). Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis. Gut. 64(4). 673–683. 65 indexed citations

11.

Verbeke, Len, Ricard Farré, Kris Covens, et al.. (2014). O2 OBETICHOLIC ACID, A FARNESOID-X RECEPTOR AGONIST, REDUCES BACTERIAL TRANSLOCATION AND RESTORES INTESTINAL PERMEABILITY IN A RAT MODEL OF CHOLESTATIC LIVER DISEASE. Journal of Hepatology. 60(1). S1–S2. 2 indexed citations

12.

Verbeke, Len, Ricard Farré, Jonel Trebicka, et al.. (2013). Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats. Hepatology. 59(6). 2286–2298. 213 indexed citations

13.

Elst, Ingrid Vander, et al.. (2011). High-frequency vagus nerve stimulation improves portal hypertension in cirrhotic rats. Gut. 61(4). 604–612. 20 indexed citations

14.

Elst, Ingrid Vander, et al.. (2010). The hepatic vagus nerve stimulates hepatic stellate cell proliferation in rat acute hepatitis via muscarinic receptor type 2. Liver International. 30(5). 693–702. 5 indexed citations

15.

Laleman, Wim, Ingrid Vander Elst, Marcel Zeegers, et al.. (2009). Carbon monoxide produced by intrasinusoidally located haem‐oxygenase‐1 regulates the vascular tone in cirrhotic rat liver. Liver International. 29(5). 650–660. 20 indexed citations

16.

Laleman, Wim, et al.. (2006). Nitroflurbiprofen (HCT-1026), a nitric oxidereleasing cyclooxygenase-inhibitor, improves cirrhotic portal hypertension in the rat without major side-effects. Hepatology. 44(4). 1 indexed citations

17.

Laleman, Wim, Ingrid Vander Elst, Marcel Zeegers, et al.. (2006). A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited. European Journal of Clinical Investigation. 36(4). 242–249. 57 indexed citations

18.

Laleman, Wim, Alexander Wilmer, Pieter Evenepoel, et al.. (2006). Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Critical Care. 10(4). R108–R108. 176 indexed citations

19.

Laleman, Wim, Tamara Severi, Ingrid Vander Elst, et al.. (2006). Both Ca²⁺-dependent and -independent pathways are involved in rat hepatic stellate cell contraction and intrahepatic hyperresponsiveness to methoxamine. American Journal of Physiology-Gastrointestinal and Liver Physiology. 292(2). G556–G564. 36 indexed citations

20.

Laleman, Wim, Marc Van de Casteele, Marcel Zeegers, et al.. (2005). A role for asymmetric dimethylarginine in the pathophysiology of portal hypertension in rats with biliary cirrhosis†‡. Hepatology. 42(6). 1382–1390. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact